KANG [iKang Healthcare] 6-K: (Original Filing)

[AMENDMENT NO. 1 TO RIGHTS AGREEMENT EXECUTION VERSION AMENDMENT NO. 1 (this “Amendment”), dated as of November 28, 2016, to the Rights Agreement (the “Rights Agreement”), dated as of December 2, 2015, by and between iKang Healthcare Group, Inc., a company incorporated under the laws of the Cayman Is]

KANG [iKang Healthcare] 6-K: AMENDMENT NO. 1 TO RIGHTS AGREEMENT EXECUTION VERSION

[AMENDMENT NO. 1 TO RIGHTS AGREEMENT EXECUTION VERSION AMENDMENT NO. 1 (this “Amendment”), dated as of November 28, 2016, to the Rights Agreement (the “Rights Agreement”), dated as of December 2, 2015, by and between iKang Healthcare Group, Inc., a company incorporated under the laws of the Cayman Is]

KANG [iKang Healthcare] 6-K: (Original Filing)

[iKang Announces Unaudited Financial Results for the First Quarter Ended June 30, 2016 BEIJING, August 31, 2016 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), the largest provider in China’s fast growing private preventive healthcare services market with a market share of 13.6% in terms of revenue in calendar year 2014, today announced its unaudited] [IKANG HEALTHCARE GROUP, INC. Yang Chen]

KANG [iKang Healthcare] 6-K: iKang Announces Unaudited Financial Results for the First

[iKang Announces Unaudited Financial Results for the First Quarter Ended June 30, 2016 BEIJING, August 31, 2016 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), the largest provider in China’s fast growing private preventive healthcare services market with a market share of 13.6% in terms of revenue in calendar year 2014, today announced its unaudited] [IKANG HEALTHCARE GROUP, INC. Yang Chen]

KANG [iKang Healthcare] 20-F: (Original Filing)

[FORM 20-F (Mark One) o OR x OR o OR o Date of event requiring this shell company report. . . . . . . . . . . . . . . . . . . . For the transition period from to iKang Healthcare Group, Inc. N/A Cayman Islands (Jurisdiction of incorporation or organization) B-6F, Shimao Tower 92A] [New China Life Insurance Co., Ltd. (“NCI”), iKang Guobin Healthcare Group Co., Ltd. (“iKang”), Shenzhen Top Spring Pu Chang Investment Management Co., Ltd. (“Top Spring Pu Chang”) and New China Life Insurance Health Investment Management Co., Ltd. (the “Target Company”) entered into the Capital Injection Agreement (the “Agreement”) on December 4, 2015, as supplemented by the Supplemental Agreement to the] [iKang Healthcare Technology Group Co., Ltd. (the “Borrower”) and AVIC Trust Co., Ltd. (the “Lender”) entered into the Loan Agreement (the “Agreement”) on December 9, 2015. Article 1. The Loan Amount The amount of loan (“Loan”) hereunder is RMB500,000,000. Article 2. Usage of the Loan. 2.1 2.2 Article 3. Term of the Loan. 3.1 3.2 1 3.3 3.4 3.5 3.6] [Shenzhen Xingwang Great Health No.1 Investment Center (Limited Partnership) (“Party A”) and iKang Healthcare Technology Group Co., Ltd. (“Party B”, or the “Company”) entered into the Investment Agreement on December 7, 2015, as supplemented by the Supplemental Agreement to the Investment Agreement dated February 14, 2016. Article 1. Terms of Loan and Conversion (1) (2) (3) (4) (5) (i) 1] [Zhongjin Zhide Equity Investment Management Co., Ltd. (“Party A”) and iKang Healthcare Technology Group Co., Ltd. (“Party B”, or the “Company”) entered into the Investment Agreement on December 11, 2015. Article 1. Terms of Loan and Conversion (1) (2) (3) (4) (5) 1 (i) (ii) (1) (2) (3) (4) 2 (5) Article 4. Event of Default (1) (2) (3) (4)] [Tianjin Junlian Yunpeng Enterprise Management Consulting Partnership (Limited Partnership) (“Party A”), iKang Healthcare Technology Group Co., Ltd. (“Party B”, or the “Company”) and Beijing Junlian Xinhai Equity Investment Partnership (Limited Partnership) (“Party C”) entered into the Investment Agreement on December 30, 2015, as supplemented by the Supplemental Agreement to the Investment Agreement dated February 14, 2016. Article 1. Terms of] [List of Subsidiaries Subsidiaries Place of Incorporation iKang Guobin Healthcare Group, Inc. British Virgin Islands iKang Zhejiang, Inc. British Virgin Islands iKang MRI Center, Inc. British Virgin Islands iKang mHealth, Inc. British Virgin Islands Yuanhua Healthcare Limited Hong Kong MediFast (Hong Kong) Limited Hong Kong Medifast (Hong Kong) Ltd. (Causeway Bay Branch) Hong Kong Medifast (Hong Kong) Ltd. (Kowloon Branch)] [I, Ligang Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [Certification by the Principal Financial Officer I, Yang Chen, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. July 29, 2016 EX-13.1 10 a16-11673_1ex13d1.htm EX-13.1] [Certification by the Principal Financial Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. July 29, 201 EX-13.2 11 a16-11673_1ex13d2.htm EX-13.2] [15.1 29 July, 2016 Matter No.:823187 Doc Ref: 102708437 +852 2842 9531 Anna.Chong@conyersdill.com Charissa.Ball@conyersdill.com The Directors iKang Healthcare Group, Inc. B-6F Shimao Tower 92A Jianguo Road Chaoyang District Beijing 100022 People’s Republic of China Dear Sirs, Re: iKang Healthcare Group, Inc. (the “Company”) Form 20-F Yours faithfully, EX-15.1 12 a16-11673_1ex15d1.htm EX-15.1] [July 29, 2016 iKang Healthcare Group, Inc. B-6F Shimao Tower, 92A Jianguo Road Chaoyang District Beijing 100022 People’s Republic of China Ladies and Gentlemen, We consent to the reference to our firm under the captions of “Item 3.D — Risk Factors” and “Item 4.C — Organizational Structure” in iKang Healthcare Group, Inc.’s annual report on Form 20-F for the year] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statements No. 333-197289 and Beijing, the People’s Republic of China July 29, 2016 EX-15.3 14 a16-11673_1ex15d3.htm EX-15.3]

KANG [iKang Healthcare] 20-F: FORM 20-F (Mark One) o OR x OR

[FORM 20-F (Mark One) o OR x OR o OR o Date of event requiring this shell company report. . . . . . . . . . . . . . . . . . . . For the transition period from to iKang Healthcare Group, Inc. N/A Cayman Islands (Jurisdiction of incorporation or organization) B-6F, Shimao Tower 92A] [New China Life Insurance Co., Ltd. (“NCI”), iKang Guobin Healthcare Group Co., Ltd. (“iKang”), Shenzhen Top Spring Pu Chang Investment Management Co., Ltd. (“Top Spring Pu Chang”) and New China Life Insurance Health Investment Management Co., Ltd. (the “Target Company”) entered into the Capital Injection Agreement (the “Agreement”) on December 4, 2015, as supplemented by the Supplemental Agreement to the] [iKang Healthcare Technology Group Co., Ltd. (the “Borrower”) and AVIC Trust Co., Ltd. (the “Lender”) entered into the Loan Agreement (the “Agreement”) on December 9, 2015. Article 1. The Loan Amount The amount of loan (“Loan”) hereunder is RMB500,000,000. Article 2. Usage of the Loan. 2.1 2.2 Article 3. Term of the Loan. 3.1 3.2 1 3.3 3.4 3.5 3.6] [Shenzhen Xingwang Great Health No.1 Investment Center (Limited Partnership) (“Party A”) and iKang Healthcare Technology Group Co., Ltd. (“Party B”, or the “Company”) entered into the Investment Agreement on December 7, 2015, as supplemented by the Supplemental Agreement to the Investment Agreement dated February 14, 2016. Article 1. Terms of Loan and Conversion (1) (2) (3) (4) (5) (i) 1] [Zhongjin Zhide Equity Investment Management Co., Ltd. (“Party A”) and iKang Healthcare Technology Group Co., Ltd. (“Party B”, or the “Company”) entered into the Investment Agreement on December 11, 2015. Article 1. Terms of Loan and Conversion (1) (2) (3) (4) (5) 1 (i) (ii) (1) (2) (3) (4) 2 (5) Article 4. Event of Default (1) (2) (3) (4)] [Tianjin Junlian Yunpeng Enterprise Management Consulting Partnership (Limited Partnership) (“Party A”), iKang Healthcare Technology Group Co., Ltd. (“Party B”, or the “Company”) and Beijing Junlian Xinhai Equity Investment Partnership (Limited Partnership) (“Party C”) entered into the Investment Agreement on December 30, 2015, as supplemented by the Supplemental Agreement to the Investment Agreement dated February 14, 2016. Article 1. Terms of] [List of Subsidiaries Subsidiaries Place of Incorporation iKang Guobin Healthcare Group, Inc. British Virgin Islands iKang Zhejiang, Inc. British Virgin Islands iKang MRI Center, Inc. British Virgin Islands iKang mHealth, Inc. British Virgin Islands Yuanhua Healthcare Limited Hong Kong MediFast (Hong Kong) Limited Hong Kong Medifast (Hong Kong) Ltd. (Causeway Bay Branch) Hong Kong Medifast (Hong Kong) Ltd. (Kowloon Branch)] [I, Ligang Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [Certification by the Principal Financial Officer I, Yang Chen, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. July 29, 2016 EX-13.1 10 a16-11673_1ex13d1.htm EX-13.1] [Certification by the Principal Financial Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. July 29, 201 EX-13.2 11 a16-11673_1ex13d2.htm EX-13.2] [15.1 29 July, 2016 Matter No.:823187 Doc Ref: 102708437 +852 2842 9531 Anna.Chong@conyersdill.com Charissa.Ball@conyersdill.com The Directors iKang Healthcare Group, Inc. B-6F Shimao Tower 92A Jianguo Road Chaoyang District Beijing 100022 People’s Republic of China Dear Sirs, Re: iKang Healthcare Group, Inc. (the “Company”) Form 20-F Yours faithfully, EX-15.1 12 a16-11673_1ex15d1.htm EX-15.1] [July 29, 2016 iKang Healthcare Group, Inc. B-6F Shimao Tower, 92A Jianguo Road Chaoyang District Beijing 100022 People’s Republic of China Ladies and Gentlemen, We consent to the reference to our firm under the captions of “Item 3.D — Risk Factors” and “Item 4.C — Organizational Structure” in iKang Healthcare Group, Inc.’s annual report on Form 20-F for the year] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statements No. 333-197289 and Beijing, the People’s Republic of China July 29, 2016 EX-15.3 14 a16-11673_1ex15d3.htm EX-15.3]

KANG [iKang Healthcare] 6-K: (Original Filing)

[iKang Announces Further Update on Potential “Going Private” Transaction BEIJING, June 9, 2016 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: The Company’s special committee of independent directors was notified that, on June 7, 2016, Mr. Zhang and certain of his affiliated entities determined to withdraw from the Founder Buyer Group and withdraw their prior going] [IKANG HEALTHCARE GROUP, INC. Yang Chen Chief Financial Officer]

KANG [iKang Healthcare] 6-K: iKang Announces Further Update on Potential “Going Private”

[iKang Announces Further Update on Potential “Going Private” Transaction BEIJING, June 9, 2016 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: The Company’s special committee of independent directors was notified that, on June 7, 2016, Mr. Zhang and certain of his affiliated entities determined to withdraw from the Founder Buyer Group and withdraw their prior going] [IKANG HEALTHCARE GROUP, INC. Yang Chen Chief Financial Officer]

KANG [iKang Healthcare] 6-K: (Original Filing)

[iKang Announces Receipt of Competing Non-Binding “Going Private” Proposal BEIJING, June 06, 2016 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: Annex A A copy of the Yunfeng Capital proposal letter is attached as The Company has previously disclosed that it received a preliminary non-binding going private proposal letter dated August 31, 2015 from Mr. Ligang] [IKANG HEALTHCARE GROUP, INC. Yang Chen Chief Financial Officer]

KANG [iKang Healthcare] SC 13D/A: June 7, 2016 FV Investment Holdings 190 Elgin

[June 7, 2016 FV Investment Holdings 190 Elgin Avenue, George Town, Grand Cayman KY1-9005 Cayman Islands Attention: TANG Kui with a copy to: Suite 705-708 ICBC Tower 3 Garden Road Central, Hong Kong Attention: Wei Cai / Eric Chen / Brian Lee Alibaba Investment Limited c/o Alibaba Group Services Limited, 26/F, Tower One, Times Square, 1 Matheson Street, Causeway Bay,] [June 7, 2016 Special Committee of the Board of Directors iKang Healthcare Group, Inc. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People’s Republic of China Dear Members of the Special Committee, Proposal Company We refer to our preliminary non-binding proposal (the “ [ Sincerely, Ligang Zhang Time Intelligent Finance Limited] []

Skip to toolbar